2019
DOI: 10.1007/978-981-13-8023-5_11
|View full text |Cite
|
Sign up to set email alerts
|

Preventive or Curative Administration of Taurine Regulates Lipid Metabolism in the Liver of Rats with Alcoholic Liver Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
9
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 43 publications
2
9
0
Order By: Relevance
“…FAS is a multienzyme protein catalysing fatty acid synthesis. 38 Our results demonstrated that SREBP-1C , HMGCR and FAS , which promote lipid synthesis, were markedly elevated by the HFD; however, aged LPT suppressed these changes. The HFD increased the SREBP-1C , HMGCR and FAS mRNA levels in the liver, identical to the results of previous studies.…”
Section: Discussionmentioning
confidence: 47%
See 1 more Smart Citation
“…FAS is a multienzyme protein catalysing fatty acid synthesis. 38 Our results demonstrated that SREBP-1C , HMGCR and FAS , which promote lipid synthesis, were markedly elevated by the HFD; however, aged LPT suppressed these changes. The HFD increased the SREBP-1C , HMGCR and FAS mRNA levels in the liver, identical to the results of previous studies.…”
Section: Discussionmentioning
confidence: 47%
“…36,37 HMGR is the ratecontrolling enzyme in the mevalonate pathway, catalysing the conversion of HMG-CoA to mevalonic acid, which is a necessary step in the production of cholesterol. 38 The increased level of HMGR in the HFD mouse liver corresponds to increased cholesterogenesis, as indicated by the higher contents of total cholesterol (TC) and LDL cholesterol (LDL-C) in the plasma. 39 FAS is a multienzyme protein catalysing fatty acid synthesis.…”
Section: Discussionmentioning
confidence: 99%
“…Mechanistically, taurine inhibits cholesterol synthesis by AMPK-SREBP2-3-hydroxyl-3-methylglutaryl-CoA reductase (HMGCR). It also serves as a direct ligand of liver X receptor α (LXRα) and elevates the hepatic low-density lipoprotein (LDL) receptor [ 76 , 103 , 105 ], regulating the reverse cholesterol transport [ 106 ]. Upon accumulation in the liver, taurine supports the conversion of cholesterol into BAs via enhancement of the cholesterol 7α-hydroxylase (CYP7A1) enzyme [ 94 , 103 , 105 , 107 , 108 , 109 ].…”
Section: Taurinementioning
confidence: 99%
“…It also serves as a direct ligand of liver X receptor α (LXRα) and elevates the hepatic low-density lipoprotein (LDL) receptor [ 76 , 103 , 105 ], regulating the reverse cholesterol transport [ 106 ]. Upon accumulation in the liver, taurine supports the conversion of cholesterol into BAs via enhancement of the cholesterol 7α-hydroxylase (CYP7A1) enzyme [ 94 , 103 , 105 , 107 , 108 , 109 ]. In addition to regulating BAs synthesis, taurine also serves as a conjugation substrate for BAs, substantially changing their properties [ 110 ].…”
Section: Taurinementioning
confidence: 99%
“…Increasing evidence indicates that proinflammatory cytokines, such as TNF-α, IL-1β and IL-6, can induce inflammatory responses and aggravate inflammatory development in ALD [26]. It has been reported that SREBP-1c is elevated in ALD and PPAR-α is decreased in ALD, but both are associated with liver damage [27]. It is…”
Section: Discussionmentioning
confidence: 99%